Retinoic acid‐loading of the major birch pollen allergen Bet v 1 may improve specific allergen immunotherapy: In silico, in vitro and in vivo data in BALB/c mice-Reference-Cited by-同舟云学术

Retinoic acid‐loading of the major birch pollen allergen Bet v 1 may improve specific allergen immunotherapy: In silico, in vitro and in vivo data in BALB/c mice

Published:2020-04-16 Issue:8 Volume:75 Page:2073-2077
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Hufnagl Karin¹^ORCID,Afify Sheriene Moussa¹²^ORCID,Braun Nina¹,Wagner Stefanie¹,Wallner Michael³^ORCID,Hauser Michael³^ORCID,Wiederstein Markus⁴^ORCID,Gadermaier Gabriele³^ORCID,Wildner Sabrina³^ORCID,Redegeld Frank A.⁵^ORCID,Blokhuis Bart R.⁵,Hofstetter Gerlinde¹^ORCID,Pali‐Schöll Isabella¹^ORCID,Roth‐Walter Franziska¹^ORCID,Pacios Luis F.⁶^ORCID,Jensen‐Jarolim Erika¹⁷⁸^ORCID

Affiliation:

1. The interuniversity Messerli Research Institute of the University of Veterinary Medicine Medical University of Vienna and University of Vienna Vienna Austria

2. Laboratory Medicine and Immunology Department Faculty of Medicine Menoufia University Shebin El‐Kom Egypt

3. Department of Biosciences University of Salzburg Salzburg Austria

4. Protein Bioinformatics Research Group Department of Biosciences University of Salzburg Salzburg Austria

5. Division of Pharmacology Utrecht Institute for Pharmaceutical Sciences Faculty of Science Utrecht University Utrecht The Netherlands

6. Centre for Plant Biotechnology and Genomics CBGP (UPM‐INIA) and Department of Biotechnology‐Plant Biology Universidad Politécnica de Madrid Madrid Spain

7. Institute of Pathophysiology and Allergy Research Center of Pathophysiology, Infectiology and Immunology Medical University Vienna Vienna Austria

8. Biomedical International R+D GmbH Vienna Austria

Funder

Austrian Science Fund

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.14259

Reference9 articles.

1. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.